Fibroblast Growth Factor Receptor 3 Interacts with and Activates TGFβ-Activated Kinase 1 Tyrosine Phosphorylation and NFκB Signaling in Multiple Myeloma and Bladder Cancer
出版年份 2014 全文链接
标题
Fibroblast Growth Factor Receptor 3 Interacts with and Activates TGFβ-Activated Kinase 1 Tyrosine Phosphorylation and NFκB Signaling in Multiple Myeloma and Bladder Cancer
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 1, Pages e86470
出版商
Public Library of Science (PLoS)
发表日期
2014-01-24
DOI
10.1371/journal.pone.0086470
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- BMP-2 Differentially Modulates FGF-2 Isoform Effects in Osteoblasts From Newborn Transgenic Mice
- (2013) Maria Giovanna Sabbieti et al. ENDOCRINOLOGY
- Epidermal Growth Factor (EGF)-enhanced Vascular Cell Adhesion Molecule-1 (VCAM-1) Expression Promotes Macrophage and Glioblastoma Cell Interaction and Tumor Cell Invasion
- (2013) Yanhua Zheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fibroblast Growth Factor Receptor 3 Is a Rational Therapeutic Target in Bladder Cancer
- (2013) K. M. Gust et al. MOLECULAR CANCER THERAPEUTICS
- Fibroblast Growth Factor Receptors-1 and -3 Play Distinct Roles in the Regulation of Bladder Cancer Growth and Metastasis: Implications for Therapeutic Targeting
- (2013) Tiewei Cheng et al. PLoS One
- FGF-2 inhibits TNF-α mediated apoptosis through up-regulation of Bcl2-A1 and Bcl-xL in ATDC5 cells
- (2012) Hey-Ryun Kim et al. BMB Reports
- Inhibition of transforming growth factor-β-activated kinase-1 blocks cancer cell adhesion, invasion and metastasis
- (2012) D M Ray et al. BRITISH JOURNAL OF CANCER
- TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers
- (2012) Anurag Singh et al. CELL
- NF- B, the first quarter-century: remarkable progress and outstanding questions
- (2012) M. S. Hayden et al. GENES & DEVELOPMENT
- Oncogenic FGFR3 gene fusions in bladder cancer
- (2012) Sarah V. Williams et al. HUMAN MOLECULAR GENETICS
- TAK1, more than just innate immunity
- (2012) Liang Dai et al. IUBMB LIFE
- The Breast Cancer Susceptibility Gene Product Fibroblast Growth Factor Receptor 2 Serves as a Scaffold for Regulation of NF- B Signaling
- (2012) W. Wei et al. MOLECULAR AND CELLULAR BIOLOGY
- Identification of fibroblast growth factor-8b target genes associated with early and late cell cycle events in breast cancer cells
- (2012) E.M. Nilsson et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Targeting of TAK1 in inflammatory disorders and cancer
- (2012) Hiroaki Sakurai TRENDS IN PHARMACOLOGICAL SCIENCES
- The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies
- (2012) A Kalff et al. Blood Cancer Journal
- Fibroblast growth factors and their receptors in cancer
- (2011) Jørgen Wesche et al. BIOCHEMICAL JOURNAL
- Low molecular weight heparin downregulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor-κB
- (2011) Camille Ettelaie et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- RNAi screen of the druggable genome identifies modulators of proteasome inhibitor sensitivity in myeloma including CDK5
- (2011) Y. X. Zhu et al. BLOOD
- RNAi Screening Identifies TAK1 as a Potential Target for the Enhanced Efficacy of Topoisomerase Inhibitors
- (2011) S. E. Martin et al. CURRENT CANCER DRUG TARGETS
- Molecular Heterogeneity of Multiple Myeloma: Pathogenesis, Prognosis, and Therapeutic Implications
- (2011) Avet-Loiseau Hervé et al. JOURNAL OF CLINICAL ONCOLOGY
- Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1
- (2011) Davide Melisi et al. JNCI-Journal of the National Cancer Institute
- Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells
- (2011) U-M Fagerli et al. ONCOGENE
- FGF-1 reverts epithelial-mesenchymal transition induced by TGF-β1 through MAPK/ERK kinase pathway
- (2010) Carlos Ramos et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence
- (2010) Pavel Krejci et al. BONE
- Small molecule FGF receptor inhibitors block FGFR-dependent urothelial carcinoma growth in vitro and in vivo
- (2010) F R Lamont et al. BRITISH JOURNAL OF CANCER
- Ablation of TAK1 Upregulates Reactive Oxygen Species and Selectively Kills Tumor Cells
- (2010) E. Omori et al. CANCER RESEARCH
- FGFR3 mutation affects cell growth, apoptosis and attachment in keratinocytes
- (2010) Christian Hafner et al. EXPERIMENTAL CELL RESEARCH
- The TAK1–TRAF6 signalling pathway
- (2010) Marene Landström INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Effects of Fibroblast Growth Factor-2 on the Expression and Regulation of Chemokines in Human Dental Pulp Cells
- (2010) Young-Suk Kim et al. JOURNAL OF ENDODONTICS
- Ectopic expression of wild-type FGFR3 cooperates with MYC to accelerate development of B-cell lineage neoplasms
- (2010) A Zingone et al. LEUKEMIA
- Sesamin Manifests Chemopreventive Effects through the Suppression of NF-κB–Regulated Cell Survival, Proliferation, Invasion, and Angiogenic Gene Products
- (2010) Kuzhuvelil B. Harikumar et al. MOLECULAR CANCER RESEARCH
- Lost in migration
- (2010) George S Mack et al. NATURE BIOTECHNOLOGY
- NF-κB addiction and its role in cancer: ‘one size does not fit all’
- (2010) M M Chaturvedi et al. ONCOGENE
- Bacteria Peptidoglycan Promoted Breast Cancer Cell Invasiveness and Adhesiveness by Targeting Toll-Like Receptor 2 in the Cancer Cells
- (2010) Wenjie Xie et al. PLoS One
- The Receptor Tyrosine Kinase FGFR4 Negatively Regulates NF-kappaB Signaling
- (2010) Kristine A. Drafahl et al. PLoS One
- Curcumin Potentiates the Antitumor Effects of Bacillus Calmette-Guerin against Bladder Cancer through the Downregulation of NF- B and Upregulation of TRAIL Receptors
- (2009) A. M. Kamat et al. CANCER RESEARCH
- Epicardium and Myocardium Separate From a Common Precursor Pool by Crosstalk Between Bone Morphogenetic Protein– and Fibroblast Growth Factor–Signaling Pathways
- (2009) Bram van Wijk et al. CIRCULATION RESEARCH
- A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells
- (2009) L. Salazar et al. HUMAN MOLECULAR GENETICS
- Comprehending the complex connection between PKCβ, TAK1, and IKK in BCR signaling
- (2009) Hisaaki Shinohara et al. IMMUNOLOGICAL REVIEWS
- NF-??B in the pathogenesis and treatment of multiple myeloma
- (2008) Zhi-Wei Li et al. CURRENT OPINION IN HEMATOLOGY
- Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells
- (2008) Melinda C. Cushing et al. FASEB JOURNAL
- Is NF-κB a good target for cancer therapy? Hopes and pitfalls
- (2008) Véronique Baud et al. NATURE REVIEWS DRUG DISCOVERY
- Analysis of STAT1 Activation by Six FGFR3 Mutants Associated with Skeletal Dysplasia Undermines Dominant Role of STAT1 in FGFR3 Signaling in Cartilage
- (2008) Pavel Krejci et al. PLoS One
- Clinical significance of nuclear factor (NF)-κB levels in urothelial carcinoma of the urinary bladder
- (2008) Georgia Levidou et al. VIRCHOWS ARCHIV
- FGF-1-induced matrix metalloproteinase-9 expression in breast cancer cells is mediated by increased activities of NF-κB and activating protein-1
- (2007) Gina Lungu et al. MOLECULAR CARCINOGENESIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started